PTGS2 and arthritic joint disease: The anti-inflammatory drug celecoxib, the only inhibitor of cyclooxygenase-2 (COX-2 inhibitor) still used in the markets, for the treatment of various forms of arthritis and the management of acute or chronic pain due to its favorable gastrointestinal toxicity profile [17].